MEI Pharma, Inc. lost $2.39 per diluted share in fiscal year 2025. This represents a decrease of 189.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters MEI Pharma, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$2.39
YoY-189.5%
Source SEC Filings (10-K/10-Q)Latest period Q3 FY2026, ended Mar 31, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
MEIP EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was MEI Pharma, Inc.'s diluted earnings per share in fiscal year 2025?
MEI Pharma, Inc. lost $2.39 per diluted share in fiscal year 2025.
How fast is MEI Pharma, Inc.'s diluted earnings per share growing?
MEI Pharma, Inc. (MEIP) diluted earnings per share fell by 189.5% year over year, from $2.67 to -$2.39 in fiscal year 2025.
What was MEI Pharma, Inc.'s diluted earnings per share in the most recent quarter?
MEI Pharma, Inc. (MEIP) reported -$0.66 in diluted earnings per share in Q3 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what MEI Pharma, Inc. (MEIP) reported on that line in every period on record.
